There were an additional eight tumors from seven VUS carriers that were not reclassified by ACMG/InSiGHT framework that were MSI-H/dMMR from tumor sequencing and demonstrated loss of the MMR protein/s concordant with the MMR gene harboring the VUS (Table 3). This evidence concerns the gene MRC1 and neoplasm.